Key facts
- This page summarizes Andrew L. Pecora's Form 4 filing for Celularity Inc (CELU).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Sep 2021, 14:48.
Andrew L. Pecora - 15 Sep 2021 Form 4 Insider Report for Celularity Inc (CELU)
- Reporting relationship
- President
- Issuer ticker
- CELU
- Reported as of
- 15 Sep 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Keary Dunn, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Andrew L. Pecora filed Form 4 for Celularity Inc (CELU) on 17 Sep 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CELU
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +2,469,282
- Change %
- Price
- $0.000000
- Shares after
- 2,469,282
- Date
- 15 Sep 2021
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 2,469,282
- Exercise price
- $6.32
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This option shall vest and become exercisable in up to five installments in respect of achieving certain share price targets between the third and fourth anniversary of the effective date, September 15, 2021, subject to the Reporting Person's continuous service on each vesting date.